[go: up one dir, main page]

JP2008538288A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538288A5
JP2008538288A5 JP2008506408A JP2008506408A JP2008538288A5 JP 2008538288 A5 JP2008538288 A5 JP 2008538288A5 JP 2008506408 A JP2008506408 A JP 2008506408A JP 2008506408 A JP2008506408 A JP 2008506408A JP 2008538288 A5 JP2008538288 A5 JP 2008538288A5
Authority
JP
Japan
Prior art keywords
inflammatory bowel
bowel disease
atcc pta
lactobacillus reuteri
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008506408A
Other languages
English (en)
Other versions
JP4740999B2 (ja
JP2008538288A (ja
Filing date
Publication date
Priority claimed from US11/107,438 external-priority patent/US7344867B2/en
Application filed filed Critical
Publication of JP2008538288A publication Critical patent/JP2008538288A/ja
Publication of JP2008538288A5 publication Critical patent/JP2008538288A5/ja
Application granted granted Critical
Publication of JP4740999B2 publication Critical patent/JP4740999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (7)

  1. ラクトバチルスロイテリ(Lactobacillus reuteri)ATCC PTA−6475である菌株
  2. 請求項1に記載の菌株の培養物由来の馴化培地を含む、炎症性腸疾患における炎症を治療するための医薬
  3. ラクトバチルスロイテリ株ATCC PTA−6475を含む、炎症性腸疾患患者に投与するための医薬。
  4. ラクトバチルスロイテリ株ATCC PTA−6475の培養物由来の馴化培地を含む、炎症性腸疾患患者に投与するための医薬。
  5. 公知の摂取可能な担体と、ラクトバチルスロイテリ株ATCC PTA−6475を含む、炎症性腸疾患における炎症を治療するのに有用な医薬組成物。
  6. 公知の摂取可能な担体と、ラクトバチルスロイテリ株ATCC PTA−6475由来の馴化培地を含む、炎症性腸疾患における炎症を治療するのに有用な医薬組成物。
  7. 請求項1記載の菌株の培養物が増殖した後のラクトバチルス馴化培地中に存在する5kDaのタンパク様物質を含む、潰瘍を治療するのに有効な医薬。
JP2008506408A 2005-04-15 2006-04-12 哺乳類における炎症を軽減するための乳酸菌の選択及び使用 Active JP4740999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/107,438 2005-04-15
US11/107,438 US7344867B2 (en) 2005-04-15 2005-04-15 Selection and use of lactic acid bacteria for reducing inflammation in mammals
PCT/SE2006/000434 WO2006110088A1 (en) 2005-04-15 2006-04-12 Selection and use of lactic acid bacteria for reducing inflammation in mammals

Publications (3)

Publication Number Publication Date
JP2008538288A JP2008538288A (ja) 2008-10-23
JP2008538288A5 true JP2008538288A5 (ja) 2010-12-02
JP4740999B2 JP4740999B2 (ja) 2011-08-03

Family

ID=37087291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008506408A Active JP4740999B2 (ja) 2005-04-15 2006-04-12 哺乳類における炎症を軽減するための乳酸菌の選択及び使用

Country Status (16)

Country Link
US (2) US7344867B2 (ja)
EP (1) EP1868622B1 (ja)
JP (1) JP4740999B2 (ja)
KR (1) KR101042123B1 (ja)
CN (1) CN101160134B (ja)
AU (1) AU2006234793B2 (ja)
DK (1) DK1868622T3 (ja)
ES (1) ES2606765T3 (ja)
HU (1) HUE032297T2 (ja)
LT (1) LT1868622T (ja)
MX (1) MX2007012656A (ja)
PL (1) PL1868622T3 (ja)
PT (1) PT1868622T (ja)
RU (1) RU2378370C2 (ja)
SI (1) SI1868622T1 (ja)
WO (1) WO2006110088A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US8785183B2 (en) * 2010-09-21 2014-07-22 Biogaia Ab Active plastic material in oil
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
ES2402014B1 (es) * 2011-09-07 2014-02-27 Consejo Superior De Investigaciones Científicas (Csic) Peptido secretado por lactobacillus plantarum con función inmunomoduladora
AU2013240289B2 (en) 2012-03-29 2018-01-25 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
PL3456334T3 (pl) * 2012-06-04 2021-05-04 Biogaia Ab Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
ES2874479T3 (es) * 2014-01-23 2021-11-05 Biogaia Ab Agentes que modulan el dolor gastrointestinal
BR112017019660A2 (en) * 2015-03-26 2018-05-15 Biogaia Ab Histamine-producing lactic acid bacterial strain and method of selecting a lactic acid bacterial strain for use
US10376563B1 (en) 2016-02-12 2019-08-13 Wisconsin Alumni Research Foundation Methods for systemically delivering polypeptides and microorganisms therefor
RS64503B1 (sr) 2016-04-15 2023-09-29 Baylor College Medicine Lactobacillus reuteri mm4-1a za upotrebu u lečenju ili prevenciji poremećaja autističnog spektra
KR102250597B1 (ko) 2017-11-20 2021-05-11 경희대학교 산학협력단 신규 유산균 및 이의 용도
CN110893195B (zh) * 2019-09-30 2023-03-14 内蒙古伊利实业集团股份有限公司 一种具有缓解肠道炎症功能的副干酪乳杆菌et-22
PL3897836T3 (pl) 2019-11-08 2023-10-30 Biogaia Ab Bakterie wytwarzające serotoninę
CN114196581B (zh) * 2020-12-16 2023-06-13 江南大学 缓解高尿酸血症的罗伊氏乳杆菌ccfm1132及应用
AU2022318574B2 (en) 2021-07-30 2024-03-21 Helaina, Inc. Methods and compositions for protein synthesis and secretion
CA3228922A1 (en) 2021-10-11 2023-04-20 Ajinomoto Co., Inc. Bacterium modified to express heterologous tat protein
KR102752058B1 (ko) * 2023-08-25 2025-01-13 전남대학교 산학협력단 락토바실러스 루터리 nchbl-005 균주, 사균체 또는 이의 혼합물을 유효 성분으로 포함하는 염증성 질환 예방, 치료 또는 개선용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US20010049115A1 (en) * 2000-01-17 2001-12-06 Collins John Kevin Vitro model for gastrointestinal inflammation
AU5773600A (en) * 1999-06-30 2001-01-31 Board Of Regents Of The University Of Nebraska, The Method of isolation of regulated virulence determinants from bacterial pathogens
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Similar Documents

Publication Publication Date Title
JP2008538288A5 (ja)
Huck et al. Akkermansia muciniphila reduces Porphyromonas gingivalis‐induced inflammation and periodontal bone destruction
JP7325130B2 (ja) プロバイオティックスの放出およびプロバイオティックス酵素活性の維持のための粘膜粘着性フィルムの調製方法
US10449222B2 (en) Method for preventing and/or treating infections, colonisations, or illnesses related to Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur
JP6505594B2 (ja) プロバイオティクス細菌
JP5121715B2 (ja) 保湿剤
JP2016529309A5 (ja)
FI2839836T4 (fi) Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita
RU2010142003A (ru) Синбиотическая смесь
JP2009539371A5 (ja)
CN105263504A (zh) 用于预防和/或治愈细菌性阴道病的包含乳酸菌的组合物
RU2010126327A (ru) Композиция на основе пробиотических бактерий совместно с пребиотиком и ее применение в предупреждении и/или лечении респираторных патологий и/или инфекций и для улучшения функций кишечника
JP2011225596A5 (ja)
JP2019500056A5 (ja)
JP2017513906A (ja) 炎症性腸疾患の治療に使用するための局所用組成物
JP2018532034A (ja) 機能性水和ヒアルロン酸及びこれを利用した優れた腸粘膜付着能及び選択的拮抗作用を有するコーティング乳酸菌の製造方法
EP2158916A1 (en) Administration unit comprising lactic acid bacteria
ME02448B (me) Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta
WO2014154025A1 (zh) 类黄酮在制药中的应用
JP2008501316A5 (ja)
JP2010505824A5 (ja)
RU2007142174A (ru) Отбор и использование молочнокислых бактерий в целях снижения степени воспаления у млекопитающих
CN111700918B (zh) 一种用于缓解酒精性肠道损伤的药品
CN108641980B (zh) 一种缓解内毒素感染的卵形拟杆菌及其应用
JP7118594B2 (ja) 止瀉剤組成物